Source:http://linkedlifedata.com/resource/pubmed/id/19362139
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2009-7-14
|
pubmed:abstractText |
Inflammation within the Central Nervous System (CNS) is largely controlled by the balance between CNS-specific effector and regulatory T lymphocytes. To suppress CNS-inflammation in an antigen-specific manner, CNS-specific effector and regulatory T cells thus have to be differentially regulated. We employed recombinant peptide/MHC class II tetramers to assess CNS-specific effector and regulatory T cells during the specific suppression of myelin proteolipid protein aa139-151 (PLP139-151)-induced experimental autoimmune encephalomyelitis (EAE) by intravenous injection of recombinant invariant chains (Ii) in which the CLIP region has been replaced by the PLP139-151 epitope (Ii-PLP139-151). Injection of Ii-PLP139-151 induced apoptosis in CNS-specific effector T cells. In contrast, the proportion of specific regulatory T cells was increased and these cells expressed larger amounts of molecules that mediate regulatory T cell function including transforming growth factor beta and the inducible costimulator (ICOS). Consequently, regulatory T cells from Ii-treated mice were more potent than regulatory T cells from control-treated animals in suppressing effector T cell proliferation. These data demonstrate that effector T cells and regulatory T cells directed against the same CNS-antigen can be differentially regulated in vivo to suppress CNS-autoimmunity. Recombinant Ii induce apoptosis in CNS-specific effector T cells and provoke qualitative changes in specific regulatory T cells that enhance their immunosuppressive properties.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1090-2139
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
861-7
|
pubmed:meshHeading |
pubmed-meshheading:19362139-Adoptive Transfer,
pubmed-meshheading:19362139-Animals,
pubmed-meshheading:19362139-Apoptosis,
pubmed-meshheading:19362139-CD4-Positive T-Lymphocytes,
pubmed-meshheading:19362139-Caspase 3,
pubmed-meshheading:19362139-Central Nervous System,
pubmed-meshheading:19362139-Encephalomyelitis, Autoimmune, Experimental,
pubmed-meshheading:19362139-Flow Cytometry,
pubmed-meshheading:19362139-Genes, MHC Class II,
pubmed-meshheading:19362139-Immune Tolerance,
pubmed-meshheading:19362139-Lymph Nodes,
pubmed-meshheading:19362139-Mice,
pubmed-meshheading:19362139-Recombinant Proteins,
pubmed-meshheading:19362139-T-Lymphocytes,
pubmed-meshheading:19362139-T-Lymphocytes, Regulatory,
pubmed-meshheading:19362139-Th2 Cells
|
pubmed:year |
2009
|
pubmed:articleTitle |
Differential modulation of CNS-specific effector and regulatory T cells during tolerance induction by recombinant invariant chains in vivo.
|
pubmed:affiliation |
Hertie Institute for Clinical Brain Research, Department of General Neurology, University of Tübingen, Hoppe-Seyler-Strasse 3, Tübingen, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|